Suppr超能文献

G蛋白偶联受体:构象与状态

G-protein coupled receptors: conformations and states.

作者信息

Strange P G

机构信息

School of Animal and Microbial Sciences, University of Reading, Whiteknights, UK.

出版信息

Biochem Pharmacol. 1999 Oct 1;58(7):1081-8. doi: 10.1016/s0006-2952(99)00144-6.

Abstract

Activation of G-protein coupled receptors by agonists is thought to involve the stabilisation of a ternary complex of agonist/receptor/G-protein, leading to effector activation, but this mechanism may be an oversimplification, as follows: (a) Agonist binding to the free receptor (uncoupled from G-proteins) is not a neutral event, but includes a component of the activation process and may be described in terms of the stabilisation of a partly activated form of the receptor (R*) that is able to couple to the G-protein. Stabilisation of R*, therefore, may contribute to agonist efficacy. Also, determinations of agonist affinity even in the absence of G-protein coupling do not necessarily describe the affinities of agonists for the ground state of the receptor. (b) R* is a partly activated intermediate between the ground state of the receptor (R) and the activated form coupled to G-protein (RG). There is some indication that different agonists may stabilise different conformational states of the receptor, i.e. different R species. (c) Agonists also stabilise the activated, coupled form of the receptor (ARG), and for some agonists acting at a single receptor, the activated states may be similar, although there is evidence for other agonists that different activated states with different activities may be stabilised. (d) Two or more efficacy-generating steps are involved in the activation of G-protein coupled receptors by agonists: the stabilisation of R, the stabilisation of RG, and possibly the modulation of the activity of the activated state (ARG). (e) The experimentally observed excess of G-proteins over receptors in membranes is inconsistent with data obtained from ligand-binding assays on these receptors. Receptors and G-proteins, therefore, may exist in some form of higher order array with cooperative interactions.

摘要

激动剂激活G蛋白偶联受体被认为涉及激动剂/受体/G蛋白三元复合物的稳定,从而导致效应器激活,但如下所述,这种机制可能过于简单:(a) 激动剂与游离受体(未与G蛋白偶联)的结合并非中性事件,而是包括激活过程的一个组成部分,并且可以用能够与G蛋白偶联的部分激活形式的受体(R*)的稳定来描述。因此,R的稳定可能有助于激动剂的效力。此外,即使在没有G蛋白偶联的情况下测定激动剂亲和力,也不一定能描述激动剂对受体基态的亲和力。(b) R是受体基态(R)和与G蛋白偶联的激活形式(RG)之间的部分激活中间体。有迹象表明,不同的激动剂可能稳定受体的不同构象状态,即不同的R种类。(c) 激动剂还稳定受体的激活偶联形式(ARG),对于作用于单个受体的一些激动剂,激活状态可能相似,尽管有证据表明其他激动剂可能稳定具有不同活性的不同激活状态。(d) 激动剂激活G蛋白偶联受体涉及两个或更多产生效力的步骤:R的稳定、RG的稳定,以及可能对激活状态(ARG)活性的调节。(e) 实验观察到膜中G蛋白相对于受体过量,这与这些受体的配体结合测定获得的数据不一致。因此,受体和G蛋白可能以某种具有协同相互作用的高阶排列形式存在。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验